BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18505782)

  • 1. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells.
    Laffont S; Seillet C; Ortaldo J; Coudert JD; Guéry JC
    Blood; 2008 Aug; 112(3):661-71. PubMed ID: 18505782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens.
    Coudert JD; Coureau C; Guéry JC
    J Immunol; 2002 Sep; 169(6):2979-87. PubMed ID: 12218112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo.
    Laffont S; Coudert JD; Garidou L; Delpy L; Wiedemann A; Demur C; Coureau C; Guéry JC
    Blood; 2006 Oct; 108(7):2257-64. PubMed ID: 16449531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response.
    Morandi B; Mortara L; Chiossone L; Accolla RS; Mingari MC; Moretta L; Moretta A; Ferlazzo G
    PLoS One; 2012; 7(6):e39170. PubMed ID: 22723958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.
    Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS
    Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable requirement of dendritic cells for recruitment of NK and T cells to different TLR agonists.
    Uchida T; Scumpia PO; Murasko DM; Seki S; Woulfe S; Clare-Salzler MJ; Moldawer LL
    J Immunol; 2007 Mar; 178(6):3886-92. PubMed ID: 17339488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells.
    Jungraithmayr W; Codarri L; Bouchaud G; Krieg C; Boyman O; Gyülvészi G; Becher B; Weder W; Münz C
    Am J Respir Crit Care Med; 2013 Jun; 187(12):1349-59. PubMed ID: 23590269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Targeting to XCR1
    Kitazawa Y; Ueta H; Sawanobori Y; Katakai T; Yoneyama H; Ueha S; Matsushima K; Tokuda N; Matsuno K
    Front Immunol; 2019; 10():1195. PubMed ID: 31191552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.
    Ge MQ; Ho AW; Tang Y; Wong KH; Chua BY; Gasser S; Kemeny DM
    J Immunol; 2012 Sep; 189(5):2099-109. PubMed ID: 22869906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity.
    Garrod KR; Liu FC; Forrest LE; Parker I; Kang SM; Cahalan MD
    J Immunol; 2010 Mar; 184(5):2329-36. PubMed ID: 20139277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo.
    Brehm MA; Daniels KA; Ortaldo JR; Welsh RM
    J Immunol; 2005 Jun; 174(11):6663-71. PubMed ID: 15905505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
    Wells JW; Cowled CJ; Darling D; Guinn BA; Farzaneh F; Noble A; Galea-Lauri J
    Cancer Immunol Immunother; 2007 Dec; 56(12):1861-73. PubMed ID: 17487489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic heart transplantation activates alloreactive NK cells.
    Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G
    Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.
    Olson JA; Leveson-Gower DB; Gill S; Baker J; Beilhack A; Negrin RS
    Blood; 2010 May; 115(21):4293-301. PubMed ID: 20233969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
    Foucras G; Coudert JD; Coureau C; Guéry JC
    J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
    Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
    Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.